ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.
about
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and ChemoresistanceCancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceAberrant activation of the hedgehog signaling pathway in malignant hematological neoplasmsNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewArsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulationProteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancerStem cell pathways contribute to clinical chemoresistance in ovarian cancerInhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cellsThe nuclear import of ribosomal proteins is regulated by mTORJNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1.NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancerHedgehog signaling regulates telomerase reverse transcriptase in human cancer cellsEvaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line.CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinomaInhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines.Hedgehog pathway as a drug target: Smoothened inhibitors in development.A genome scale RNAi screen identifies GLI1 as a novel gene regulating vorinostat sensitivity.Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell LinesA rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialSmoothened antagonists reverse taxane resistance in ovarian cancer.Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma.The mesenchymal tumor microenvironment: a drug-resistant niche.Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells.The Hedgehog pathway: role in cell differentiation, polarity and proliferationDetection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols.GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma.Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1.Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphomaTargeting hedgehog signaling in cancer: research and clinical developments.ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma.GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli.YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.New insight into hedgehog signaling in hematological malignancies.Efflux transporters in blood-brain interfaces of the developing brain
P2860
Q26775006-597F2561-9A3B-419E-981D-35F16E38FE53Q26785497-2E4B13DA-8CA7-4AD0-9B19-19FC036DB3F1Q26865927-92DF9CF3-484E-4249-A968-A7BFA647D218Q26866139-CC80B5BE-1E80-449A-A10D-C2327355885DQ27304386-0FD8A217-72E2-4855-BD78-D10AFB8FC7BAQ28534552-25FF5CDC-9763-4084-9BA3-DF901661365FQ30410019-B15BA0E9-C53D-4CF3-9316-7ACD164D69B5Q33689071-D5BADE26-716C-47E8-A0FC-295F6721BBB5Q34092005-B9CDBC47-8901-4A75-9BFF-1C9D965A5F52Q34328051-2A4F15D4-E92F-4B7F-A7BF-A21FA6075FB1Q34654485-F0F93AD8-C2CA-4CF0-8A3A-A0EC40F373A0Q34655380-A1F69920-BE80-4AEE-A7E9-5D65764A6D1EQ34898683-05667367-77C6-4333-83A6-987586673F5EQ35005479-EC9118A6-859D-4AAB-89DE-27D118EF8A2DQ35333542-4E52304E-14AD-4C9C-9B84-3490EA5155D4Q35551864-CAF39D62-0B04-455A-B946-CBD13D307FF3Q35709668-99D0CD92-3AAC-487F-B40D-305D591F2F7DQ35885181-9F1C2BAF-E1DC-41C4-A73A-7C9E80157225Q35921565-35F85206-1E7F-44A7-BDEE-546F9BA971ACQ35946125-542D1B68-D4A8-4C8B-930C-B1EE32B492B5Q36028412-B0BB193B-2822-4A07-8F16-ED7098B0ABC6Q36084215-256E1C4F-7EE3-45BE-8BB3-D411393491B5Q36173809-B68AA69F-CFC1-4043-9D6B-991A598ACD52Q36187755-F1BB5021-54AD-4FED-A4DF-324DEE0FD16DQ36217436-F21AC75B-E64C-4558-A779-71C6F54AB998Q36240079-645B39F1-36AD-4855-8D83-FE91F09D5B45Q36316305-E38069A5-D863-48EC-95E3-24FFB869AA04Q36545242-BD0C1B26-5186-4598-9BB1-9363A640BF82Q36547802-1FF83FFC-A1BE-4185-8AB2-573CAC3DCE2AQ36873743-2D485363-90FD-40C8-B197-1A44039D527DQ36907842-C20A79E1-F656-49C0-B66A-2AB79DCBEA80Q37232227-190D6E64-C432-4588-A0AE-D933D95C68E4Q37285224-0EC6B9B4-5F45-4FE1-9518-8584DEEA1C59Q37365043-3162750B-88D7-4512-A6F9-0E9D08F9B600Q37493442-C25F5AA7-62F3-49FE-8C7A-FE8B6CD1F855Q37706137-930E033C-6A62-4731-8688-91C37DFFADD1Q38104413-5A903355-9F8B-407B-A522-ABB1A89AA481Q38132359-73AD3FA3-F1CE-4483-8A8A-83BA9F71EFE5Q38225894-D13C3308-8F46-4527-BC66-F48DD760F93AQ38362582-2F4C8F2F-F498-464D-8CC3-AA6985935303
P2860
ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma.
@ast
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma.
@en
type
label
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma.
@ast
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma.
@en
prefLabel
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma.
@ast
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma.
@en
P2093
P2860
P356
P1433
P1476
ABCG2 is a direct transcriptio ...... diffuse large B-cell lymphoma
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.195
P407
P577
2011-05-30T00:00:00Z